Intraductal papillary mucinous neoplasms of the pancreas (IPMNs) are increasingly recognized in clinical practice. They are a unique clinicopathologic entity that is characterized by mucin production, ...

All cases of IPMT, diagnosed in our institution between March 1995 and June 2004, were analyzed. According to the preoperative localization of the IPMT, different types of pancreatic resection were ...

A research team at Duke Health has identified a set of biomarkers that could help to distinguish whether cysts on the pancreas are likely to develop into cancer or remain benign. The team carried out ...

(SALT LAKE CITY)—Cancer of the pancreas is usually not detected until it's too late to cure. But precursor lesions that form in the pancreas and its ducts can signal the disease before it strikes, and ...

A University of California San Francisco (UCSF)-led team of international researchers says it has outlined the immune landscape and microbiome of pancreatic cysts as they progress from benign cysts to ...

An international, UCSF-led research team reveal has outlined the comprehensive immune landscape and microbiome of pancreatic cysts as they progress from benign cysts to pancreatic cancer. Pictured ...

The ever-increasing use of radiographic imaging of the abdomen, in particular by CT and MRI, has led to a significant rise in the discovery of patients with pancreatic cysts. Often these are ...

SAN DIEGO--(BUSINESS WIRE)--Biological Dynamics, Inc., a leader in exosome enrichment technology for early disease detection, will present a “lightning talk” as part of the “Understanding Pre-cancers ...

SAN DIEGO--(BUSINESS WIRE)--Biological Dynamics, a life sciences company focused on developing and commercializing exosome isolation technology for earlier disease detection, will present data showing ...